Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends in Primary Aldosteronism Screening Among High-Risk Hypertensive Adults.
Kositanurit W, Giacona JM, Xie D, Wang J, Feuer D, O'Malley KJ, Navar AM, Vaidya A, Cohen JB, Vongpatanasin W. Kositanurit W, et al. Among authors: navar am. J Am Heart Assoc. 2024 Aug 6;13(15):e036373. doi: 10.1161/JAHA.124.036373. Epub 2024 Jul 31. J Am Heart Assoc. 2024. PMID: 39082409 Free article. No abstract available.
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry.
Navar AM, Shah NP, Shrader P, Thomas LE, Ahmad Z, Allred C, Chamberlain AM, Chrischilles EA, Dhalwani N, Effron MB, Hayek S, Jones LK, Kalich B, Shapiro MD, Wójcik C, Peterson ED. Navar AM, et al. Am Heart J. 2024 Jul 6:S0002-8703(24)00165-0. doi: 10.1016/j.ahj.2024.06.012. Online ahead of print. Am Heart J. 2024. PMID: 38972336
Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice.
De Oliveira-Gomes D, Joshi PH, Peterson ED, Rohatgi A, Khera A, Navar AM. De Oliveira-Gomes D, et al. Among authors: navar am. Circulation. 2024 Jul 2;150(1):62-79. doi: 10.1161/CIRCULATIONAHA.124.068885. Epub 2024 Jul 1. Circulation. 2024. PMID: 38950110 Review.
Sex Differences in Cardiovascular Outcomes and Cholesterol-Lowering Efficacy of PCSK9 Inhibitors: Systematic Review and Meta-Analysis.
Rivera FB, Cha SW, Aparece JP, Rocimo A, Ong BA, Golbin JM, Alfonso PG, Enkhmaa B, Khan SU, Cainzos-Achirica M, Volgman AS, Navar AM, Shah NP. Rivera FB, et al. Among authors: navar am. JACC Adv. 2023 Oct 28;2(9):100669. doi: 10.1016/j.jacadv.2023.100669. eCollection 2023 Nov. JACC Adv. 2023. PMID: 38938736 Free PMC article.
Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events.
Mortensen MB, Jensen JM, Rønnow Sand NP, Kragholm K, Blaha MJ, Grove EL, Sørensen HT, Olesen K, Maeng M, Løgstrup B, Busk M, Hauge EM, Navar AM, Bøtker HE, Nørgaard BL. Mortensen MB, et al. Among authors: navar am. J Am Coll Cardiol. 2024 Jun 25;83(25):2643-2654. doi: 10.1016/j.jacc.2024.04.030. J Am Coll Cardiol. 2024. PMID: 38897674
Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN.
Nicholls SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, Ballantyne CM, Ray KK, Navar AM, Nissen SE, Golberg AC, Brunham LR, Curcio D, Wuerdeman E, Neild A, Kling D, Hsieh A, Dicklin MR, Ference BA, Laufs U, Banach M, Mehran R, Catapano AL, Davidson MH. Nicholls SJ, et al. Among authors: navar am. Am Heart J. 2024 Aug;274:32-45. doi: 10.1016/j.ahj.2024.05.002. Epub 2024 May 4. Am Heart J. 2024. PMID: 38705341 Free article. Clinical Trial.
183 results